Clinical Trials Directory

Trials / Completed

CompletedNCT02834624

Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
22 Weeks – 35 Weeks
Healthy volunteers
Not accepted

Summary

Premature infants frequently have trouble breathing after birth. If the respiratory disorder is caused by surfactant deficiency or dysfunction, the disease is treated with a medication called surfactant that is given to the infant through a tube inserted into the windpipe. This study will compare the safety of two of the commonly used surfactants, poractant and calfactant,in the United States. Poractant has added chemicals called phospholipids which are known to cause inflammation and irritation in the body of premature infants. The investigators will compare this to another similar surfactant that does not contain these chemicals by looking at samples from the windpipe, while the tube is in place, and from blood tests in the first few days of life. The investigators are hoping to learn whether calfactant is a safer therapeutic agent to treat respiratory distress syndrome in preterm infants compared to poractant.

Detailed description

30 infants were randomized to receive either poractant or calfactant for Respiratory Distress Syndrome. Tracheal aspirates were obtained to look for increase in macrophage and blood samples were drawn to look for markers of inflammation.

Conditions

Interventions

TypeNameDescription
DRUGPoractant alfaRandomized to receive Curosurf as the surfactant to treat respiratory distress syndrome. Doses 3ml/kg. to be repeated as needed by determination of attending neonatologist.
DRUGcalfactantRandomized to receive Infasurf as the surfactant to treat respiratory distress syndrome. Doses 3ml/kg. to be repeated as needed by determination of attending neonatologist

Timeline

Start date
2013-07-01
Primary completion
2015-02-01
Completion
2015-07-01
First posted
2016-07-15
Last updated
2017-06-06
Results posted
2017-06-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02834624. Inclusion in this directory is not an endorsement.